RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION • NOT FOR VETERINARY USE
QUALITY

Transparency • Traceability • Service

Our quality framework is designed to connect supplier documentation, incoming inventory, and lot-specific records.

Supplier Qualification

Our planned supplier-review process includes maintaining supplier identification, purchasing records, and available documentation associated with incoming research materials.

Document Review

Available Certificates of Analysis and analytical records are reviewed for their stated product identity, batch number, reported results, and relationship to the inventory received.

Lot Traceability

Our planned record system links supplier batch information, assigned F3 lot numbers, inventory status, and available supporting documentation.

Controlled Availability

Products remain unavailable while receipt, documentation review, inventory verification, and applicable sales eligibility checks are pending.

Research-Only Positioning

Our catalog is presented for legitimate laboratory, analytical, and scientific research. Products are not marketed for human or veterinary consumption, dosing, treatment, or medical benefit.

Record Access

Batch Vault™ is being developed to make available lot-specific records easier to locate once inventory has completed the applicable review process.

CURRENT DOCUMENTATION STATUS

Supplier records received. Verification pending.

F3 Biosciences has received seven supplier-provided Certificates of Analysis covering products in its planned initial catalog.

These documents contain supplier-reported analytical results. They have not been independently authenticated or confirmed against physical inventory.

Supplier COAs are not equivalent to independent third-party testing commissioned by F3 Biosciences. We do not represent the reported results as independently verified.

VIEW BATCH VAULT™ →

Planned inventory review

  • Confirm product identity and received quantity
  • Inspect packaging and vial labeling
  • Match supplier batch identifiers to documentation
  • Review available analytical records
  • Assign internal F3 lot identification
  • Record release or quarantine status
Documentation disclosure: Seven products currently have supplier-provided COAs on file. Semaglutide 5 mg and standalone TB-500 5 mg do not currently have supplier COAs on file. Documentation availability does not establish independent verification, product approval, or authorization for sale.